Relmada Therapeutics
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income. The net income raised on -$98,791,746 over the previous period. Total operating expenses were $103,702,000.
Profit Margin
| 2013 | 5.12K | -45.01K | -877.66% |
|---|---|---|---|
| 2015 | 0 | -20.80M | |
| 2016 | 0 | -2.97M | |
| 2018 | 0 | -8.96M | |
| 2019 | 0 | -17.31M | |
| 2019 | 0 | -15.00M | |
| 2020 | 0 | -59.45M | |
| 2021 | 0 | -125.75M | |
| 2022 | 0 | -157.04M | |
| 2023 | 0 | -98.79M |
RLMD Income Statement (2013 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.12K |
Cost of revenue | 0 | 0 | 1.25K | 3.75K | 0 | 4.87K | 2.62K | 54.81K | 9.25K | 4.03K |
Gross profit | 0 | 0 | -1.25K | -3.75K | 0 | -4.87K | -2.62K | -54.81K | -9.25K | 1.09K |
Operating exp. | ||||||||||
Research and development | 54.80M | 113.32M | 90.62M | 35.97M | 7.85M | 7.02M | 2.94M | 6.20M | 7.87M | 0 |
Selling and marketing | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.03K |
Total operating expenses | 103.70M | 161.24M | 125.70M | 60.83M | 15.10M | 12.72M | 6.91M | 16.21M | 17.09M | 46.10K |
Operating income | -103.70M | -161.24M | -125.70M | -60.83M | -15.10M | -12.72M | -6.91M | -16.21M | -17.09M | -45.01K |
Other income (expenses), net | 4.91M | 1.54M | -1.24M | 1.38M | 104.11K | -3.82M | -2.04M | 13.24M | -3.70M | 0 |
Income before tax | -98.79M | -157.04M | -125.75M | -59.45M | -15.00M | -17.31M | -8.96M | -2.97M | -20.80M | -45.01K |
Income tax expense | 0 | -2.65M | 48.31K | -1.38M | -1 | 4.59M | 2.04M | -13.11M | 3.70M | 0 |
Net income | -98.79M | -157.04M | -125.75M | -59.45M | -15.00M | -17.31M | -8.96M | -2.97M | -20.80M | -45.01K |
Earnings per share | ||||||||||
Basic EPS | -3.28 | -5.3 | -7.16 | -3.81 | -1.63 | -2.74 | -2.86 | -1.03 | -8.37 | -0.03 |
Diluted EPS | -3.28 | -5.3 | -7.16 | -3.81 | -1.63 | -2.74 | -2.86 | -1.03 | -8.37 | -0.03 |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |